Brief: Verastem Oncology Announces Debt Refinancing with Oberland Capital and Strategic Commercialization Partnership with IQVIA

Verastem

13/01/2025 13:50

Jan 13 (Reuters) - Verastem Inc  VSTM.O :
    * VERASTEM ONCOLOGY ANNOUNCES DEBT REFINANCING WITH OBERLAND
CAPITAL AND STRATEGIC COMMERCIALIZATION PARTNERSHIP WITH IQVIA
TO SUPPORT POTENTIAL LAUNCH IN RECURRENT KRAS MUTANT LOW-GRADE
SEROUS OVARIAN CANCER IN MID-2025
    * VERASTEM INC - SECURES $150 MILLION CREDIT FACILITY AND
$7.5
MILLION EQUITY INVESTMENT

Source text:  ID:nBw5YwYGSa 
Further company coverage:  VSTM.O 

 ((Reuters.Briefs@thomsonreuters.com;))